| mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
8e-06 |
| mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
7e-05 |
| mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
9e-05 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0004 |
| mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0009 |
| mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |
| mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |